Evidence map›Paper›PMID 40205254›Full record

ArticleBioresources and bioprocessing2025

Lignocellulose-derived inhibitors can extend residence of Clostridium beijerinckii in active solventogenic state.

K Koppova, L Burianova, P Patakova, B Branska

Abstract read
In one paragraph

Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advances in the biological production of butyric acid.World journal of microbiology & biotechnology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

K KoppovaDepartment of Biotechnology, University of Chemistry and Technology Prague, Technická 5, Prague, 16628, Czech Republic.
L BurianovaDepartment of Biotechnology, University of Chemistry and Technology Prague, Technická 5, Prague, 16628, Czech Republic.
P PatakovaDepartment of Biotechnology, University of Chemistry and Technology Prague, Technická 5, Prague, 16628, Czech Republic.
B BranskaDepartment of Biotechnology, University of Chemistry and Technology Prague, Technická 5, Prague, 16628, Czech Republic. barbora.branska@vscht.cz.ORCID http://orcid.org/0000-0001-6536-7063

Funding

Grantová Agentura České Republiky 23-06941S
6 · The paper itself

Abstract

Lignocellulose is a promising renewable resource for producing platform chemicals, such as acetone, butanol, and ethanol, via ABE fermentation by solventogenic clostridia. This study investigates the effects of common lignocellulose derived inhibitory compounds: ferulic acid, coumaric acid, and furfural on Clostridium beijerinckii. Dual-staining with propidium iodide and CFDA, combined with flow cytometry, was employed to assess physiological variability. The results showed that phenolic acid-induced stress helped maintain a higher proportion of viable cells during the production phase, enhancing solvent yields and reducing sporulation. At 0.4 g/L, ferulic and coumaric acids did not reduce cell viability; however, coumaric acid exposure led to an acid-crash profile. Conversely, a more robust inoculum exposed to both phenolic acids simultaneously exhibited effects similar to ferulic acid alone, including slower viability decline, reduced growth and sporulation, and improved solvent production. Furfural exposure at 1.5 g/L resulted in immediate viability loss in 20% of the population, though the overall decline accompanied by the highest sporulation rate occurred later than in the control. Additionally, furfural transformation was slower, suppressing butyrate production and reducing solvent production by 13%. This study suggests that delaying cell death mechanism may explain the stimulatory effects of inhibitors, advancing lignocellulose use in the future.

Indexed as

ABEButanolCarboxyfluorescein diacetateClostridium beijerinckiiCytometryLignocellulose inhibitorsViability

Identifiers

PMID40205254
PMCPMC11982004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.